• ChaC1-Guided Drug Screening: A New Era for FDA Compound Libr

  2026-07-30

  Explore how ChaC1-driven glutathione depletion informs pharmacological target discovery and drug repositioning in hepatocellular carcinoma. This thought-leadership article integrates mechanistic insights, translational strategy, and best practices for leveraging the DiscoveryProbe™ FDA-approved Drug Library (SKU: L1021) in advanced screening workflows. Learn how recent ChaC1-based screening studies redefine the competitive landscape, and why APExBIO’s curated compound collection is pivotal for next-generation cancer and neurodegenerative disease research.

• Anlotinib Hydrochloride Blocks Angiogenesis via VEGFR2/PDGFR

  2026-07-30

  The referenced study demonstrates that Anlotinib hydrochloride, a multi-target tyrosine kinase inhibitor, robustly inhibits angiogenesis by simultaneously suppressing VEGFR2, PDGFRβ, and FGFR1 signaling pathways. This work provides mechanistic and comparative evidence for Anlotinib’s superior anti-angiogenic activity, highlighting its value for cancer research targeting endothelial cell migration and tube formation.

• Plant Cell Lysis Buffer for WB and IP: Precision Protein Ext

  2026-07-29

  Explore how Plant Cell Lysis Buffer for WB and IP enables reliable, non-denaturing protein sample preparation from plant tissues for Western blotting and immunoprecipitation. This article offers a deep dive into buffer composition, experimental protocol, and translational impact, going beyond existing mechanistic content.

• SLU-PP-332 as a Pan-ERR Agonist: Exercise Mimicry and Mitoch

  2026-07-29

  Billon et al. characterized SLU-PP-332 as a potent synthetic agonist for ERRα, ERRβ, and ERRγ, demonstrating its capacity to induce an acute aerobic exercise gene program and increase exercise endurance in mice. The study establishes SLU-PP-332 as a robust tool for probing mitochondrial biogenesis and skeletal muscle adaptation mechanisms in vivo.

• 3X (DYKDDDDK) Peptide: Enhancing FLAG-Tag Protein Workflows

  2026-07-28

  The 3X (DYKDDDDK) Peptide delivers superior sensitivity and flexibility for affinity purification and immunodetection of FLAG-tagged proteins. Explore optimized protocols, real-world troubleshooting, and practical insights from breakthrough tumor suppressor research.

• Redox Precision: Resazurin Assay Strategies for Translationa

  2026-07-28

  Explore the mechanistic power and translational value of the Resazurin Cell Viability Assay Kit in high-sensitivity, non-toxic detection of cell proliferation, with strategic insights for oncology and beyond. This thought-leadership article bridges redox biology, workflow optimization, and clinical trajectory—grounded in peer-reviewed evidence and advanced protocol guidance.

• Isoprinosine: Strategic Immunomodulation in Viral Research

  2026-07-27

  This article explores the mechanistic and translational landscape of Isoprinosine (inosine pranobex) as a next-generation immunomodulatory agent. Integrating insights from herpesvirus biology and recent advances in nuclear egress mechanisms, we provide strategic guidance for researchers aiming to optimize antiviral immunotherapy and acute respiratory infection models. The discussion contextualizes Isoprinosine's unique dual-action profile, its competitive positioning, and future research directions, while highlighting APExBIO's commitment to enabling cutting-edge discovery.

• Structural Basis of Nipah Virus Polymerase Complex Function

  2026-07-27

  This study elucidates the high-resolution structure of the Nipah virus polymerase complex, providing unprecedented insight into the molecular organization and interaction of its L and P proteins. These findings lay a crucial foundation for targeted antiviral drug development against Nipah and related RNA viruses.

• Carfilzomib Amplifies Iodine-125-Induced Multi-Modal Cell De

  2026-07-26

  This study demonstrates that Carfilzomib (PR-171), an irreversible proteasome inhibitor, significantly enhances the efficacy of Iodine-125 seed brachytherapy in esophageal squamous cell carcinoma (ESCC) by intensifying endoplasmic reticulum stress. The findings reveal that this combination induces apoptosis, paraptosis, and ferroptosis via distinct stress pathways, offering a basis for new radiosensitization strategies in resistant ESCC.

• Kitasamycin Efficacy and Resistance in Swine Dysentery Contr

  2026-07-25

  This study systematically assessed kitasamycin’s (leucomycin) utility for controlling swine dysentery in experimentally infected pigs, revealing both its therapeutic potential against susceptible Brachyspira hyodysenteriae isolates and the prevalence of macrolide resistance. The findings inform translational inhibition studies and resistance mechanism research, highlighting key considerations for antibacterial drug discovery workflows.

• 6-FAM SE: Precision Fluorescent Dye for Robust Molecular Lab

  2026-07-24

  6-FAM SE (6-Carboxyfluorescein N-hydroxysuccinimide ester) delivers unmatched stability and sensitivity for DNA, protein, and peptide labeling in advanced molecular assays. This article details stepwise protocols, troubleshooting strategies, and workflow enhancements, translating cutting-edge research into actionable best practices.

• Selective Nanomolar IRAP Inhibitors via α-Hydroxy-β-Amino Ac

  2026-07-24

  The reference study introduces a highly selective, nanomolar inhibitor of insulin-regulated aminopeptidase (IRAP) based on innovative α-hydroxy-β-amino acid derivatives of bestatin. Through advanced synthetic and structural approaches, the authors provide valuable chemical tools for probing M1 zinc aminopeptidase biology and future drug development.

• Aminopeptidase Inhibition Reveals Angiotensin III as Active

  2026-07-23

  Harding and Felix (1987) demonstrated that the aminopeptidase inhibitor bestatin hydrochloride markedly enhances neuronal responses to angiotensin II and III in rat brain, supporting the hypothesis that angiotensin II must be enzymatically converted to angiotensin III to achieve full neuroactivity. Their findings clarify a key step in central angiotensin signaling, with implications for research in neuroendocrine regulation and targeted peptide interventions.

• DNA Damage Drives Selective CUX2 Neuron Loss in Neuroinflamm

  2026-07-23

  This study uncovers how heightened DNA damage specifically compromises CUX2-expressing neurons in cortical layers 2/3 during neuroinflammation, such as in multiple sclerosis. Through mechanistic experiments, the authors pinpoint failed DNA repair as a driver of neuron vulnerability, with implications for understanding neurodegeneration and potential for targeted DNA damage modeling in research.

• DAPI Solution (1 mg/mL): Precision Nuclear Visualization in

  2026-07-22

  DAPI Solution (1 mg/mL) from APExBIO delivers reliable, high-contrast nuclear staining for apoptosis and viability assays in fixed and permeabilized cells. Its consistent performance and compatibility with fluorescence microscopy and flow cytometry make it indispensable for cell death, senescence, and nuclear morphology studies.

15514 records 1/1035 page Next 12345 下5页 Last page